Kane Biotech Presents Revyve Research For Military Wound Care Applications

Kane Biotech (KNE.V) said research on its revyve antimicrobial wound care technology was presented at the Military Health System Research Symposium, underscoring potential use in prolonged field care and military wound management. The update is constructive for product positioning, but it does not provide financial guidance or trial outcomes that would likely move the stock meaningfully.